Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.

MLA

Little, Tanya J., et al. “Plasma Endocannabinoid Levels in Lean, Overweight, and Obese Humans: Relationships to Intestinal Permeability Markers, Inflammation, and Incretin Secretion.” American Journal of Physiology. Endocrinology and Metabolism, vol. 315, no. 4, Oct. 2018, pp. E489–95. EBSCOhost, https://doi.org/10.1152/ajpendo.00355.2017.

APA

Little, T. J., Cvijanovic, N., DiPatrizio, N. V., Argueta, D. A., Rayner, C. K., Feinle-Bisset, C., & Young, R. L. (2018). Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion. American Journal of Physiology. Endocrinology and Metabolism, 315(4), E489–E495. https://doi.org/10.1152/ajpendo.00355.2017

Chicago

Little, Tanya J, Nada Cvijanovic, Nicholas V DiPatrizio, Donovan A Argueta, Christopher K Rayner, Christine Feinle-Bisset, and Richard L Young. 2018. “Plasma Endocannabinoid Levels in Lean, Overweight, and Obese Humans: Relationships to Intestinal Permeability Markers, Inflammation, and Incretin Secretion.” American Journal of Physiology. Endocrinology and Metabolism 315 (4): E489–95. doi:10.1152/ajpendo.00355.2017.